|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Non cash expense | |||||
| Interest Expense | |||||
| Interest and other income, net | |||||
| Property, plant and equipment written off | |||||
| Provision for credit loss reserve, net | |||||
| Shares issued to investors and advisors | |||||
| Deferred income tax benefit | |||||
| Stock compensation expense | |||||
| Provision for slow moving inventory | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventory, net | |||||
| Deferred revenue | |||||
| Prepaids and other assets | |||||
| Accounts payable and accrued expenses | |||||
| Accounts payable | |||||
| Income taxes payable, net | |||||
| Accrued expenses & other liabilities | |||||
| Operating lease payment | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Notes Receivables - Acquisition | |||||
| Long Term Receivable | |||||
| Loans & Advances (Related Party) | |||||
| Purchase of property, plant and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common stock against warrants and options | |||||
| Repayments of Notes payable | |||||
| Proceeds from bank overdraft facility (net) | |||||
| Proceeds from securities offering | |||||
| Repayment of warrants | |||||
| Proceeds from issuance of promissory notes to principal shareholder | |||||
| Right of use liability,non current portion | |||||
| Proceeds from issuance of convertible notes to principal shareholder | |||||
| Proceeds from issuance of convertible notes to other investors | |||||
| Repayment of convertible notes to principal shareholder, including interest | |||||
| Repayment of convertible notes to other investors, including interest | |||||
| Proceeds from warrant exercised pending allotment | |||||
| Net cash provided by financing activities | |||||
| Net change in cash | |||||
| Effect of exchange rate on cash | |||||
| Cash and cash equivalents at the beginning of the year | |||||
| Cash and cash equivalents at end of the year | |||||
| Transfer of systems from inventory to property, plant and equipment | |||||
| Supplemental disclosure of cash flow information: | |||||
| Conversion of convertible notes into common stock, including interest | |||||
| Transfer of systems from inventory to property, plant and equipment | |||||
| Transfer of systems from property, plant and equipment to inventory | |||||
Loading...